[Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry].
In the diagnosis of metabolic myopathies the use of biochemical methods, in addition to morphological examination of muscle biopsies, is often necessary in order to identify a specific metabolic defect. In order to narrow down the spectrum of biochemical methods, extensive clinical investigation and morphological examination, including histology, enzyme histochemistry and electromicroscopy if necessary have to be done beforehand. Patients are classified in the following groups: 1) progressive muscular weakness and/or muscle wasting with storage of a) glycogen, b) lipid or c) mitochondrial alterations; 2) recurrent rhabdomyolysis induced by fasting or exercise a) with glycogen storage or b) without any specific morphological alterations. The spectrum of metabolic defects comprises disorders of glycogen and glucose metabolism (deficiency of acid maltase, debranching and branching enzyme, phosphorylase, phosphofructokinase and other glycolytic enzymes), lipid metabolism (carnitine deficiency, carnitine palmitoyl transferase deficiency), mitochondria (respiratory chain disorders, pyruvate dehydrogenase deficiency) and others such as adenylate deaminase deficiency. In some of these e.g. infantile acid maltase deficiency and mitochondriopathies, it is clinically more important when organs other than muscle are affected; however, muscle biopsy is a useful substrate for diagnosis of these metabolic disorders.
D000328:Adult; D001706:Biopsy; D002331:Carnitine / Q000172:deficiency; D003937:Diagnosis, Differential; D004591:Electrophoresis, Polyacrylamide Gel; D006008:Glycogen Storage Disease / Q000150:complications; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000150:complications*; D009135:Muscular Diseases / Q000209:etiology / Q000378:metabolism / Q000473:pathology*
D002331:Carnitine
Diagnostische Bedeutung von Muskelbiopsien bei metabolischen Myopathien. II. Klinische Biochemie.